Poulin Y - Search Results

1

Incorporating biologics into the treatment of psoriasis.

Lui H, Langley R, Poulin Y, Gupta AK, Carey W, Guenther L, Searles G, Toole J, Lynde C, Gulliver W, Barber K. Lui H, et al. Among authors: poulin y. J Cutan Med Surg. 2004 Aug;8 Suppl:8-13. doi: 10.1007/s10227-004-2003-6. J Cutan Med Surg. 2004. PMID: 15655584 Review. No abstract available.

2

A comparison of tazarotene 0.1% gel once daily plus mometasone furoate 0.1% cream once daily versus calcipotriene 0.005% ointment twice daily in the treatment of plaque psoriasis.

Guenther LC, Poulin YP, Pariser DM. Guenther LC, et al. Among authors: poulin yp. Clin Ther. 2000 Oct;22(10):1225-38. doi: 10.1016/s0149-2918(00)83065-9. Clin Ther. 2000. PMID: 11110233 Clinical Trial.

3

Treatment of acne vulgaris and prevention of acne scarring: canadian consensus guidelines.

Madden WS, Landells ID, Poulin Y, Searles GE, Smith KC, Tan JK, Toole J, Zip CM, Degreef H. Madden WS, et al. Among authors: poulin y. J Cutan Med Surg. 2000 Jun;4 Suppl 1:S2-13. J Cutan Med Surg. 2000. PMID: 11749902

4

Topical treatment of actinic keratoses with 3.0% diclofenac in 2.5% hyaluronan gel.

Rivers JK, Arlette J, Shear N, Guenther L, Carey W, Poulin Y. Rivers JK, et al. Among authors: poulin y. Br J Dermatol. 2002 Jan;146(1):94-100. doi: 10.1046/j.1365-2133.2002.04561.x. Br J Dermatol. 2002. PMID: 11841372 Clinical Trial.

5

A multicenter, double-blind, randomized comparison study of the efficacy and tolerability of once-daily tazarotene 0.1% gel and adapalene 0.1% gel for the treatment of facial acne vulgaris.

Webster GF, Guenther L, Poulin YP, Solomon BA, Loven K, Lee J. Webster GF, et al. Cutis. 2002 Feb;69(2 Suppl):4-11. Cutis. 2002. PMID: 12095066 Clinical Trial.

6

Psoriasis today--a new paradigm.

Poulin Y. Poulin Y. J Cutan Med Surg. 2004 Aug;8 Suppl:1-2. doi: 10.1007/s10227-004-2001-8. J Cutan Med Surg. 2004. PMID: 15655582 No abstract available.

7

Pathogenesis of psoriasis and current challenges.

Gupta AK, Langley R, Poulin Y, Lui H, Searles G, Carey W, Toole J, Inniss K. Gupta AK, et al. Among authors: poulin y. J Cutan Med Surg. 2004 Aug;8 Suppl:3-7. doi: 10.1007/s10227-004-2002-7. J Cutan Med Surg. 2004. PMID: 15655583 No abstract available.

8

The use of alefacept in the treatment of psoriasis.

Langley R, Gupta AK, Poulin Y, Guenther L, Barber K, Gulliver W, Lynde C. Langley R, et al. Among authors: poulin y. J Cutan Med Surg. 2004 Aug;8 Suppl:14-8. doi: 10.1007/s10227-004-2004-5. J Cutan Med Surg. 2004. PMID: 15655585 Review. No abstract available.

9

Integrating biologic agents into management of moderate-to-severe psoriasis: a consensus of the Canadian Psoriasis Expert Panel. February 27, 2004.

Guenther L, Langley RG, Shear NH, Bissonnette R, Ho V, Lynde C, Murray E, Papp K, Poulin Y, Zip C. Guenther L, et al. Among authors: poulin y. J Cutan Med Surg. 2004 Sep-Oct;8(5):321-37. doi: 10.1007/s10227-005-0035-1. J Cutan Med Surg. 2004. PMID: 15868311

10

Strategies for optimizing treatment with efalizumab in moderate to severe psoriasis.

Papp KA, Ho V, Langley R, Lynde C, Poulin Y, Shear N, Toole J, Zip C. Papp KA, et al. Among authors: poulin y. J Cutan Med Surg. 2006;9 Suppl 1:26-32. doi: 10.1007/s10227-006-0104-0. J Cutan Med Surg. 2006. PMID: 16633859 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

184 results

Search Page

Filters